Tag: Merck

Merck drops oncolytic virus therapy Cavatak (V937)

ADC评论 October 29, 2022

On October 27, Merck announced its third-quarter financial report, and its product pipeline no longer includes the oncolytic virus therapy Cavatak (V937) obtained from the

Latest: Merck to buy Seagen fails to agree on price

ADC评论 August 27, 2022

According to Bloomberg, citing people familiar with the matter, the two companies have so far failed to agree on a price in talks to acquire

Merck and Cerevance collaborate to explore new targets for Alzheimer’s disease

ADC评论 August 11, 2022

On August 10, Merck and Cerevance announced that they have reached a strategic cooperation agreement to use Cerevance’s proprietary NETSseq transcriptomic technology platform to discover